Identifying non-coding RNAs for therapy to limit the development of heart failure

Application consists of completing an online application. To apply, please visit the King’s Apply website at https://myapplication.kcl.ac.uk/

We are seeking exceptional and highly motivated candidates for an interdisciplinary PhD studentship aiming to identify non-coding RNAs that can be used for therapy to limit the development of heart failure. Potential therapeutic non-coding RNAs will be identified using the high content screening facility within our BHF Centre of Excellence. Those identified will then be evaluated after nanoparticle delivery in a mouse model of heart failure. In Dr Burgoyne’s lab the student will learn molecular and biochemical techniques, as well as in vivo cardiac models of heart failure. While Dr de Rosales’s lab will provide advanced training in nanoparticle delivery systems and in in vivo PET imaging.

The programme welcomes applications from a diverse range of backgrounds. Applicants will be reviewed on qualifications, experience and potential to undertake a research degree.

To be eligible for consideration applicants must possess, or be expected to achieve, a 1st or good upper 2nd class degree (or equivalent) in a relevant subject. A 2:2 degree may be considered only where applicants also offer a Master’s degree with Merit or above.

English Language Requirements

If English is not your first language you will be required to provide evidence that you meet the minimum English requirements of the Faculty details can be found on our website. If you are unable to provide this confirmation before applying any offer you are made would be conditional upon you meeting these requirements prior to enrolment and no later than 4 weeks before the course starts.

Fore further details and information on how to apply please visit the studentship webpage